Correlation Between Morgan Stanley and COMPUGROUP MEDSPADR

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and COMPUGROUP MEDSPADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and COMPUGROUP MEDSPADR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and COMPUGROUP MEDSPADR 1, you can compare the effects of market volatilities on Morgan Stanley and COMPUGROUP MEDSPADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of COMPUGROUP MEDSPADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and COMPUGROUP MEDSPADR.

Diversification Opportunities for Morgan Stanley and COMPUGROUP MEDSPADR

0.76

Correlation Coefficient

Morgan Stanley  COMPUGROUP MEDSPADR

Poor diversification

The 3 months correlation between Morgan and COMPUGROUP is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and COMPUGROUP MEDSPADR 1 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMPUGROUP MEDSPADR and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with COMPUGROUP MEDSPADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMPUGROUP MEDSPADR has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and COMPUGROUP MEDSPADR go up and down completely randomly.

Pair Corralation between Morgan Stanley and COMPUGROUP MEDSPADR

Given the investment horizon of 90 days Morgan Stanley is expected to generate 152.32 times less return on investment than COMPUGROUP MEDSPADR. But when comparing it to its historical volatility, Morgan Stanley Direct is 9.5 times less risky than COMPUGROUP MEDSPADR. It trades about 0.01 of its potential returns per unit of risk. COMPUGROUP MEDSPADR 1 is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1,400  in COMPUGROUP MEDSPADR 1 on September 24, 2024 and sell it today you would earn a total of  680.00  from holding COMPUGROUP MEDSPADR 1 or generate 48.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.24%
Values	Daily Returns

Morgan Stanley Direct  vs.  COMPUGROUP MEDSPADR 1

Morgan Stanley Direct

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

COMPUGROUP MEDSPADR

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in COMPUGROUP MEDSPADR 1 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, COMPUGROUP MEDSPADR reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and COMPUGROUP MEDSPADR

The main advantage of trading using opposite Morgan Stanley and COMPUGROUP MEDSPADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, COMPUGROUP MEDSPADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMPUGROUP MEDSPADR will offset losses from the drop in COMPUGROUP MEDSPADR's long position.

The idea behind Morgan Stanley Direct and COMPUGROUP MEDSPADR 1 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.